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Background: The management of dizziness in older patients is primarily diagnosis-oriented. However, in 40 % of
older patients with dizziness, GPs are not able to identify an underlying cause, and a number of common
underlying causes of dizziness cannot (or hardly) be treated. In this study we will investigate the effectiveness of a
prognosis-oriented approach in the management of dizziness in older patients. This prognosis-oriented approach
comprises identification of patients at risk for chronic dizziness with persistent impairment by identifying risk factors
for an unfavourable course of dizziness. Patients at risk for chronic dizziness with persistent impairment will be
offered treatment addressing the identified modifiable risk factors.
Methods/Design: This study will be performed in primary care. An intervention study and a validation study will
be conducted in a three-arm cluster randomised design. In the intervention study we will investigate a risk factor
guided multi-component intervention. The risk factor guided intervention includes: (1) medication adjustment in
case of three or more prescribed fall-risk-increasing drugs, (2) stepped care in case of anxiety disorder and/or
depression, and (3) exercise therapy in case of impaired functional mobility. The primary outcome measure is
dizziness-related impairment, which will be assessed with the Dizziness Handicap Inventory. Secondary outcome
measures are quality of life, anxiety disorder and depression, use of fall-risk-increasing drugs, dizziness frequency, fall
frequency, and healthcare utilization.
Discussion: This study is, to date, the first study that will investigate the effectiveness of a prognosis-oriented
approach for reducing dizziness-related impairment in older people in primary care. Offering treatment that
addresses identified modifiable risk factors to patients at high risk for chronic dizziness is unique. The pragmatic
design of this study will enable evaluation of the outcomes in real-life routine practice conditions. An effective
intervention will not only reduce dizziness-related impairment, but may also decrease healthcare utilization and
healthcare costs. The previously developed risk score that will be validated alongside the intervention study will
enable GPs to identify patients at high risk for chronic dizziness with persistent impairment.
Trial registration: Netherlands Trial Register (identifier: NTR4346), registration date 15 December 2013.
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Dizziness occurs frequently in older people. The preva-
lence of dizziness in older people ranges from 8 % in the
primary care population to 30 % in the community, and
increases with age [1–7]. For doctors, dizziness is a chal-
lenging entity to deal with: patients use the term dizzi-
ness for a variety of sensations, and the complaint
dizziness may accompany harmless but also very serious
conditions. Dizziness is a fuzzy concept that can refer to
several sensations, including a giddy or rotational sensa-
tion, a loss of balance, a faint feeling, light-headedness,
instability or unsteadiness, a tendency to fall, or a feeling
of everything turning black [8]. Dizziness in older people
can have serious consequences. Dros et al. reported that
more than 60 % of older dizzy people in primary care
experience moderate or severe impact on daily living
due to dizziness [9]. Furthermore, dizziness is associated
with worsening of depressive symptoms, self-rated health,
and social activities [10]. Older people who experience
dizziness also have an increased fall risk [10], leading to
injury and high healthcare costs [11]. Hartholt et al.
showed that 3 % of all Dutch people aged ≥65 years yearly
visit the emergency department due to falling, resulting in
a mean cost of €9370 per fall, increasing to €14,600 per
fall in patients aged ≥80 years [11].
Most guidelines on dizziness tend to advocate a
diagnosis-oriented approach regardless of the age of the
patient [12, 13]. The diagnosis-oriented approach starts
with a search for the cause of dizziness, and treatment
follows once an illness is diagnosed. For several reasons,
this diagnosis-oriented approach may be insufficient in
older patients presenting with dizziness. Firstly, in 40 %
of older patients with dizziness GPs are not able to iden-
tify an underlying cause [1]. Secondly, a number of com-
mon underlying causes of dizziness cannot be treated
(such as polyneuropathy) or hardly treated (such as
orthostatic hypotension). Finally, clinicians may identify
causes of dizziness for which treatment is available but
not desirable (such as the Epley manoeuvre for benign
paroxysmal position vertigo in patients with severe cer-
vical arthrosis). Croft et al. recently stated that many ill-
nesses cannot usefully be labelled from a disease-
diagnosis perspective [14]. They argued that in such
cases, a prognostic model can provide an alternative
framework for clinical practice that extends beyond dis-
ease and diagnosis, and incorporates a wide range of in-
formation to predict future patient outcomes and to
guide decisions to improve them [14].
Tinetti et al. suggested that dizziness in the aged may
constitute a multifactorial geriatric syndrome [4, 15].
Geriatric syndromes, such as delirium, falls, incontin-
ence, and frailty, are highly prevalent, multifactorial, and
associated with substantial morbidity and poor outcomes
[16]. Research on contributory factors for dizziness inolder people has strengthened the idea of dizziness in
the aged as being a geriatric syndrome [17–21]. Several
researchers presume that a multifactorial intervention,
targeting contributory factors of the geriatric dizziness
syndrome, might reduce dizziness and dizziness-related
impairment [4, 8, 15, 17, 18, 21]. To date, the effective-
ness of such a multifactorial approach has not been in-
vestigated. In this study, aged patients with dizziness will
be offered a multi-component intervention in a so-called
prognosis-oriented approach. This prognosis-oriented
approach focuses on the identification of modifiable risk
factors for an unfavourable course of dizziness, after
which treatment will be offered that addresses the modi-
fiable risk factors [22].
The aim of this study is to evaluate the effectiveness of
a prognosis-oriented approach in older people with diz-
ziness in primary care. We will perform an intervention
study to investigate the effectiveness of a risk factor-
guided intervention for treating dizziness in older pa-
tients. This risk factor-guided intervention consists of
the following interventions: (1) medication adjustment in
case of ≥3 prescribed fall-risk-increasing drugs (FRIDs),
(2) stepped care in case of anxiety and/or depression,
and (3) exercise therapy in case of impaired functional
mobility. Alongside this intervention study we will val-
idate a previously developed seven-item risk score for
chronic dizziness with persistent impairment in older
people [19].Methods/Design
The study has a three-arm design to perform both an
intervention study and a validation study with a 1-year
prospective follow-up period (Fig. 1). The intervention
study is a cluster randomized controlled trial, designed
to investigate the effectiveness of a risk factor-guided
multi-component intervention for treating dizziness in
older patients. The aim of the validation study is to valid-
ate a previously developed risk score for chronic dizziness
with persistent impairment in older people in primary
care [19]. Patients will be assigned to one of three study
groups: the intervention group (Fig. 1, group A), the ob-
servational cohort (Fig. 1, group B), and the control group
(Fig. 1, group C). In the intervention study, the interven-
tion group and the control group will be compared. The
validation study comprises the observational cohort and
the control group.
The study was approved by the Medical Ethics Review
Committee of VU University Medical Center (approval
number: NL49604.029.14), and will be conducted ac-
cording to the principles of the Declaration of Helsinki
(version 2013) and the Dutch Medical Research Involv-
ing Human Subjects Act (WMO). For this paper, we
followed the Consolidated Standards of Reporting Trials
Fig. 1 Flow chart of the study. * High risk or low risk of chronic dizziness with persistent impairment. DHI Dizziness Handicap Inventory, MHNP
mental health nurse practitioner, GP general practitioner, pharm pharmacologist, physio physiotherapist
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mised trials [23].
Sample and setting
Patients will be recruited from 46 general practices in an
urban area in the Netherlands. Patients of 65 years and
older are eligible to participate in the study if they have
consulted their general practitioner (GP) for dizziness in
the preceding 3 months, and if they are significantly im-
paired by their dizziness. We define dizziness as recur-
rent dizziness for at least 1 month, including a giddy or
rotational sensation, loss of balance, faint feeling, light-
headedness, instability, and/or tendency to fall [8]. The
Dizziness Handicap Inventory (DHI) will be used to as-
sess impairment due to dizziness. A DHI score of ≥30
corresponds with significant impairment due to dizzi-
ness [24]. Exclusion criteria are severe cognitive impair-
ment, terminal illness, severe psychiatric problems, and
the inability to speak, read and write Dutch.Randomisation
In the intervention study, cluster randomisation at prac-
tice level will be conducted to avoid contamination.
General practices will be randomised by a researcher
who is blinded to their identity (concealment of alloca-
tion) before the inclusion of patients begins. Practices
will be stratified by list size into practices with up to
400, 400 to 800, and over 800 patients of 65 years and
older. For each stratum, block randomisation with vary-
ing block size will be used to create similar distributions
in the study arms. The investigator is also blinded to the
size of each block.
Sample size calculation
We intend to include a total of 300 subjects. The sample
size calculation for our intervention study is based on
the difference in change in 1-year DHI score between
the intervention group and the control group. We con-
sider a DHI score difference of 11 or more to be clinically
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correlation coefficient of 0.05, and the assumption of a
loss to follow-up of 20 %, a sample of 100 patients in both
the intervention and control group is needed.
To calculate the sample size of the validation study, a
commonly used rule of thumb is followed that at least
10 events per variable are available for developing diag-
nostic and prognostic models. The previously developed
risk score that will be validated consists of seven predic-
tors and estimates the functional prognosis of dizziness
at 6 months. With the assumption that 60 % of the pa-
tients with a DHI score ≥30 at baseline will have a DHI
score of ≥30 after 6 months of follow-up [26], a sample
of 100 patients in both the observational cohort and the
control group will enable validation of the previously de-
veloped risk score.
Recruitment
Patients will be recruited by the GPs via two routes.
Firstly, GPs will invite patients to participate in the study
during consultation hours. Secondly, every 3 months
older patients with dizziness will be identified by search-
ing the electronic medical records (EMRs) in all partici-
pating general practices. The search in the EMRs will be
executed by searching for International Classification of
Primary Care (ICPC) codes N17 (dizziness) and H82
(vertiginous syndromes), and free text words dizz*, ver-
tig*, and the Dutch equivalent for ‘dizz’.
All patients will receive an invitation letter from their
GP including study information and the DHI to assess
impairment due to dizziness. Patients interested in par-
ticipating will be asked to send back a completed DHI to
the researcher. The researcher will contact all patients
with a DHI score of ≥30 to arrange an appointment for
baseline assessment at the patient’s home. Before the
start of baseline assessment, written informed consent
will be obtained from each participant.
Assignment to study groups
Assignment to one of the three study groups (Fig. 1) is
based on the risk of chronic dizziness with persistent
impairment, which will be assessed during baseline as-
sessment at the patient’s home. An older patient with
dizziness will be labelled as having a high risk for
chronic dizziness with persistent impairment if they have
a DHI score of ≥30 at baseline and the presence of one,
two, or three of the following risk factors: (1) three or
more prescribed FRIDs, (2) anxiety disorder and/or de-
pression, and (3) impaired functional mobility.
Patients with a high risk of chronic dizziness will partici-
pate in the intervention group or control group, depend-
ing on whether their general practice is an intervention
practice or control practice respectively. Older patients
with dizziness with significant impairment, but at low riskof chronic dizziness with persistent impairment, will be al-
located to the observational cohort.
In sum, the intervention study consists of a control
group with patients with dizziness-related impairment
and a high risk of chronic dizziness that will receive usual
care (Fig. 1, group C), and an intervention group that re-
ceives usual care plus one, two, or three interventions
(Fig. 1, group A). In sum, the intervention study consists
of impaired dizzy patients with a ‘high risk’ that will re-
ceive usual care in the control group (Fig. 1, group C) and
usual care plus 1, 2, or 3 interventions in the intervention
group (Fig. 1, group C).
Interventions
All patients of the intervention group (n = 100) will re-
ceive usual care plus one, two, or three risk factor-
guided interventions. The offered interventions are:
(1) medication adjustment in case of three or more
prescribed FRIDs; (2) stepped care in case of anxiety
disorder and/or depression; and (3) exercise therapy in
case of impaired functional mobility. Patients eligible
for more than one intervention will start the applic-
able interventions at the same time.
Medication adjustment in case of three or more fall-risk-
increasing drugs
This intervention will be similar to the ‘FRID with-
drawal’ study by Van der Velde et al. [27, 28]. The list of
FRIDs includes psychotropic drugs (sedatives, antide-
pressants, and neuroleptics), cardiovascular drugs (anti-
hypertensives, nitrates, anti-arrhythmics, nicotinic acid,
and β-adrenoceptor blocker eye drops), and other drugs
(analgesics, anti-vertiginous drugs, hypoglycaemics, and
urinary antispasmodics) [27]. Once a month, a pharma-
cist and an independent GP will have a meeting to re-
view the FRID use of all patients eligible for the
intervention ‘medication adjustment’ that have been
included in the preceding month. In every individual
patient, all potential FRIDs will be considered for with-
drawal. The use of FRIDs will be stopped if no health
risks are involved, or reduced in dose when stopping is
not an option. The FRID medication advice will be
handed to the patient’s GP, who will be asked to invite
the patient on his or her consultation hour to discuss
the FRID medication advice. FRID medication adjust-
ment will only take place if both the GP and the pa-
tient agree.
Stepped care for anxiety disorder and/or depression
Older patients with dizziness in the intervention group
with the risk factor ‘anxiety disorder and/or depression’
(defined as the presence of generalised anxiety disorder
(GAD), panic disorder (PD) or major depressive disorder
(MDD)), will be offered a stepped care program, based
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orders [29] and the Trimbos Multidisciplinary Guideline
Depression [30]. The presence of GAD, PD, and/or
MDD will be assessed by the Generalised Anxiety
Disorder-7 (GAD-7) [31], Patient Health Questionnaire
Panic Module (PHQ-PD) [32], and Patient Health
Questionnaire-9 (PHQ-9) [33, 34], respectively.
The offered stepped-care program involves four subse-
quent evidence-based treatment steps for anxiety dis-
order and depression in primary care, lasting 6 weeks
each. A mental health nurse-practitioner (MHNP) work-
ing in the patient’s own general practice will guide the
patient through the steps of the program. All participat-
ing MHNPs will receive a training before the start of the
intervention. If needed, the GP will be available for the
MHNP to discuss a patient. The patient flow through
the stepped care program depends on the patient’s
symptom level, as measured with the GAD-7, PHQ-PD,
and PHQ-9 at the end of every step. Patients who still
have elevated anxiety or depression symptom scores (a
GAD-7 score ≥10, a PHQ-9 score ≥10, or a positive
PHQ-PD score) after concluding a step will be invited to
participate in the next step. The steps are listed below:
Step 1 (watchful waiting): The first 6 weeks consists of
watchful waiting. At the start of step one the
MHNP will invite the patient for an introductory
consultation. The patient will get acquainted with
the MHNP and the MHNP will inform the patient
about the stepped-care program. No therapy will be
offered during step one.
Step 2 (guided self-help treatment): During this step the
patient will start with a guided self-help course of
6 weeks. The course is based on Lewinsohn’s
‘Coping with Depression’ course [35] and modified
for patients of 65 years and over who suffer from
anxiety disorder and/or depression. The course
includes of six modules that last a week each. The
patient will read about new insights and skills and
is challenged to perform exercises. The consecutive
modules focus on acknowledgment of being
anxious or depressed, relaxation, pleasant activity
scheduling, changing of cognitions, and
assertiveness. The MHNP will call the patient every
2 weeks.
Step 3 (problem-solving treatment; PST): PST is a brief
cognitive behavioural intervention that focuses on
practical skill building, education, and managing
anxiety and/or depression symptoms. The goal is to
reduce mental health problems by stimulating an
active attitude towards everyday problems [36]. PST
will be offered by the MHNP and takes a maximum
of six sessions of 30 min at the GP surgery. The
stages of problem-solving are explained during thesessions and then applied to problems that are
encountered in daily life.
Step 4 (referral to the GP): The GP will have a
consultation with the patient to assess what would
be an appropriate next therapy for the patient (for
example, starting with antidepressants or referral to
a psychologist). The GP will then initiate the
treatment.
Exercise therapy in case of impaired functional mobility
Older patients with dizziness-related impairment in the
intervention group with the risk factor ‘impaired func-
tional mobility’ (defined as a Timed Up-and-Go score of
20 s or more [37]), will receive standardized exercise
therapy by a physiotherapist of the patient’s choice.
Physical exercise therapy has a positive effect on mobil-
ity and physical functioning in mobility limited and/or
physically disabled older patients [38]. We choose for an
individual intervention because the effect of individual
interventions seems to be somewhat larger than the
effect of group interventions [38]. The aim of exercise
therapy is to improve resistance and balance because
this might improve strength and balance, which are
often implicated as a cause of mobility impairment [39].
The intervention implies training of one hour twice a
week for 8 weeks. Every training session starts with exer-
cises on sitting balance, static standing balance, and
trunk stability. The program then continues with seated
leg press, cable lat pulldown, cycling, and concludes with
walking on the treadmill. The physiotherapists will re-
ceive study information and a treatment protocol that is
designed together with a senior physiotherapist specia-
lised in exercise programs. The treatment protocol pre-
scribes what exercises should be carried out every week
and includes pictures of the specific exercises. The treat-
ment protocol is designed to give individualised care: the
intensity of the exercise therapy will be adjusted accord-
ing to the patients’ physical condition that will be tested
during the intake.
Usual care
Patients in the control group and the observational co-
hort will have unrestricted access to usual care: no treat-
ment will be denied to any participants nor will it be
postponed. The GPs of control practices will not be in-
formed about the intervention and will not receive any
training. Instead, they will be asked to provide care as
recommended in the guideline ‘Dizziness’ of the Dutch
College of General Practitioners [13].
Primary outcome measure
All primary and secondary outcome measures are
summed up in Table 1. The intervention group and con-
trol group will be followed up on at 3, 6, and 12 months;
Table 1 Overview of measurements and instruments
Validation study Intervention study
baseline 6 months 12 months baseline 3 months 6 months 12 months
Baseline assessment x x
Dizziness Handicap (DHI) x x x x x x x
QoL (EQ-5D-5L) x x x x x x
Depression (PHQ-9) x x x x x x x
Anxiety (GAD-7) x x x x x x x
Health care utilisation (EMR) x x
Panic disorder (PHQ-PD) x x x x x x x
FRID count x x x x
Dizziness and fall frequency (calendar) —————————————— weekly —————————————
DHI dizziness handicap inventory, EMR electronic medical records, FRID Fall-risk-increasing drug, GAD-7 Generalised Anxiety Disorder-7, PHQ-9 Patient Health
Questionnaire-9, QoL Quality of Life, PHQ-PD Patient Health Questionnaire Panic Module
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12 months.
The primary clinical outcome is dizziness-related im-
pairment, which will be assessed using the DHI [24].
The DHI is a widely used self-report questionnaire, de-
signed to quantify the impact of dizziness on everyday
life, with scores ranging from 0 to 100. A DHI score
of ≥30 correlates with current significant impairment
because of dizziness [24]. In the intervention study, the
primary outcome is the difference in change in 1-year
DHI score between patients in the intervention group
and patients in the control group. For the validation
study, we will dichotomise all DHI scores (<30 or ≥30).
Secondary outcome measures
Secondary outcome measures that will be measured in
both the intervention study and the validation study are
quality of life, presence of anxiety disorder and/or de-
pression, and healthcare utilisation. Furthermore, in the
intervention study dizziness frequency, fall frequency,
and difference in FRID count will also be measured.
Quality of life, will be measured with the Euro Quality
of Life-5-dimension, 5-level (EQ-5D-5L) [40]. The EQ-
5D-5L is a questionnaire that assesses health in five di-
mensions (mobility, self-care, usual activities, pain and/
or discomfort, and anxiety and/or depression).
Presence of anxiety disorder and/or depression will be
measured with GAD-7, PHQ-PD, and PHQ-9 [31–34].
Healthcare utilization: after informed consent, we will
extract data from the general practitioners’ EMRs of all
participating patients to assess the number of consulta-
tions, prescriptions, referrals, hospital admissions, and
nursing home admissions.
Dizziness frequency and fall frequency, defined as the
number of episodes of dizziness and falls per day, week,
month, and year, will be assessed using a calendar filled in by
the patient during a 12-month period. The calendar is similarto a fall calendar used in an earlier study [41], and is designed
to monitor dizziness frequency additionally to fall frequency.
Difference in FRID count, defined as the difference in
number of prescribed FRIDs between baseline and at
12 months follow-up, will also be measured.
Statistical analysis
Intervention study
We will use descriptive statistics to describe the study
population. Dropout and loss to follow-up will be
described. The primary analysis will be an intention-
to-treat analysis. We will also perform a per-protocol
analysis. Univariate and multivariate analyses will be
used to compare the outcomes of the intervention
group and control group. Regardless of whether inter-
vention patients received one, two, or three interven-
tions, the overall change in 1-year DHI-score in the
intervention group will be compared to the change in
1-year DHI-score in the control group. We will use a
repeated-measures mixed-effect model to assess differ-
ences in the overall change in 1-year DHI score in the
intervention group and control group, adjusted for po-
tential confounders. Furthermore subgroup analysis
will be performed for three groups separately that re-
ceived one of three interventions. The overall change in
1-year DHI score in these three subgroups will be com-
pared to the overall change in 1-year DHI score in the
control group.
Validation study
Descriptive statistics will be used to describe the study
population. Dropout and loss to follow-up will be de-
scribed. The validity of our seven-item risk score in this
study group will be quantified by assessing the reliability,
discrimination, and calibration of the model [42]. The
reliability of the model will be quantified with the
Hosmer-Lemeshow goodness-of-fit statistic. We will
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dicted probabilities against the observed frequencies of
persistent dizziness-related impairment. We will assess
the discriminative ability of the model, that is, its ability
to distinguish patients with dizziness and persistent
dizziness-related impairment from patients with dizzi-
ness but without persistent dizziness-related impair-
ment, by calculating the receiver operating characteristic
curve (AUC). An AUC of 0.5 indicates no discrimin-
ation above chance, whereas an AUC of 1.0 indicates
perfect discrimination. We will bootstrap to adjust for
over-optimism in model performance.
Discussion
This study is expected to add evidence on the effective-
ness of a prognosis-oriented approach for dizziness in
older people in primary care. The risk factor-guided
intervention of this prognosis-oriented approach will
provide the GP with more tools for treatment, even if
diagnosis is not (yet) available. An important aim of the
intervention study is to reduce dizziness-related impair-
ment in older patients. The intervention may also lead
to a decrease in healthcare costs by a reduction of
healthcare utilisation in secondary and tertiary care. Fur-
thermore, the availability of a new effective intervention
for older patients with dizziness may stimulate GPs to
reduce unnecessary drug prescribing [43]. Alongside the
intervention study we will validate a previously devel-
oped seven-item risk score for chronic dizziness with
persistent impairment [19]. Once validated, this risk
score will enable GPs to identify patients at high risk for
chronic dizziness with persistent impairment.
A strength of this study is that it is, to date, the first
study that will investigate the effectiveness of a prognosis-
oriented approach on reducing dizziness-related impair-
ment in a large group of older people in primary care.
Several researchers have suggested that a multi-component
intervention targeting contributory factors of the geriatric
syndrome dizziness may reduce dizziness and dizziness im-
pairment [4, 8, 15, 17, 18, 21]. Yet this study goes even fur-
ther by applying a prognosis-oriented approach instead of
a general multifactorial approach. The prognosis-oriented
approach focuses on modifiable risk factors for an un-
favourable course of dizziness, whereas the multifactorial
approach focuses on random contributory factors for the
geriatric syndrome dizziness. Also, Croft et al. recently ar-
gued that patient prognosis can provide the framework for
modern clinical practice for more effective and efficient
care [14]. Another strength of this study is the pragmatic
design, enabling evaluation of the outcomes in real-life
routine practice conditions. The pragmatic design in-
creases the generalizability of our outcomes and increases
the possibility of implementing the prognosis-oriented
approach in daily clinical practice.Due to the nature of the interventions, it will not be pos-
sible to blind patients and caregivers to the interventions.
To avoid contamination within practices, we have chosen a
cluster randomised design: GPs and MHNPs in control
practices will not receive training, as opposed to GPs and
MHNPs in intervention practices who will. Offering several
interventions to a single patient might make measurement
of the effects of the separate interventions impossible.
However, based on earlier research we expect that the ma-
jority of patients (60 %) will be eligible for only one inter-
vention (additional analysis, [26]). This will also enable us
to analyse the effects of the individual interventions.
In summary, the overall aim of this study is to demon-
strate that a prognosis-oriented approach is more effect-
ive than usual care when treating dizziness in older
patients in primary care. We will do this by measuring
the effectiveness of a multi-component intervention for
dizziness. Alongside the intervention study we will valid-
ate a previously developed seven-item risk score for
chronic dizziness with persistent impairment.
Trial status
The collection of data started in January 2015. The first
study results are expected in 2016.
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